| |
AmSurg Names John W. Popp, Jr., M.D. To Board of Directors
Mon Nov 23 (Business Wire)
NASHVILLE, Tenn.----AmSurg Corp. , today announced the appointment of John W. Popp, Jr., M.D. to its Board of Directors. Dr. Popp is Clinical Professor of Medicine at the University of South Carolina School of Medicine and a Medical Director for Centocor, Inc., a unit of Johnson and Johnson, which provides innovative biomedicines for debilitating immune disorders.
|
|
Top-Ranked Analysts
|
Provided by StarMine
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 14B | | Price
/ Earnings: | 14.1 | | Price
/ Book: | -6.3 | | Net
Profit Margin (mrq): | 3.2% | | Price
To Free Cash Flow (mrq): | 14.8 | | Return
on Equity: | 15.3% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 0.1% |
|
